Curaleaf Holdings Stock EBITDA
| CURLF Stock | USD 2.10 0.02 0.96% |
Curaleaf Holdings fundamentals help investors to digest information that contributes to Curaleaf Holdings' financial success or failures. It also enables traders to predict the movement of Curaleaf OTC Stock. The fundamental analysis module provides a way to measure Curaleaf Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Curaleaf Holdings otc stock.
Curaleaf |
Curaleaf Holdings OTC Stock EBITDA Analysis
Curaleaf Holdings' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Curaleaf Holdings EBITDA | 287.7 M |
Most of Curaleaf Holdings' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Curaleaf Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Curaleaf Holdings reported earnings before interest,tax, depreciation and amortization of 287.7 M. This is 67.21% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The ebitda for all United States stocks is 92.62% higher than that of the company.
Curaleaf EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Curaleaf Holdings' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Curaleaf Holdings could also be used in its relative valuation, which is a method of valuing Curaleaf Holdings by comparing valuation metrics of similar companies.Curaleaf Holdings is currently under evaluation in ebitda category among its peers.
Curaleaf Holdings ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Curaleaf Holdings' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Curaleaf Holdings' managers, analysts, and investors.Environmental | Governance | Social |
Curaleaf Fundamentals
| Return On Equity | -0.0776 | |||
| Return On Asset | 0.0226 | |||
| Profit Margin | (0.1) % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 4.72 B | |||
| Shares Outstanding | 623.38 M | |||
| Shares Owned By Insiders | 32.36 % | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Book | 2.36 X | |||
| Price To Sales | 2.56 X | |||
| Revenue | 1.21 B | |||
| Gross Profit | 687.59 M | |||
| EBITDA | 287.7 M | |||
| Net Income | (101.73 M) | |||
| Cash And Equivalents | 187.12 M | |||
| Cash Per Share | 0.26 X | |||
| Total Debt | 434.12 M | |||
| Debt To Equity | 0.56 % | |||
| Current Ratio | 2.44 X | |||
| Book Value Per Share | 2.32 X | |||
| Cash Flow From Operations | (33.96 M) | |||
| Earnings Per Share | (0.15) X | |||
| Price To Earnings To Growth | (2.23) X | |||
| Target Price | 7.98 | |||
| Number Of Employees | 5.6 K | |||
| Beta | 1.78 | |||
| Market Capitalization | 2.65 B | |||
| Total Asset | 3.26 B | |||
| Z Score | 3.6 | |||
| Net Asset | 3.26 B |
About Curaleaf Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Curaleaf Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curaleaf Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curaleaf Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Curaleaf OTC Stock
Curaleaf Holdings financial ratios help investors to determine whether Curaleaf OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Curaleaf with respect to the benefits of owning Curaleaf Holdings security.